Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17574065 | 0.83 | DGAT1 (0.44) | DGAT1 | |
| SCHEMBL8209867 | 0.79 | DGAT1 (0.38) | DGAT1 | |
| SCHEMBL786780 | 0.78 | DGAT1 (0.41) | DGAT1 | |
| SCHEMBL10093742 | 0.76 | DGAT1 (0.39) | DGAT1 | |
| SCHEMBL12690948 | 0.76 | DGAT1 (0.39) | DGAT1 | |
| SCHEMBL10027501 | 0.76 | DGAT1 (0.39) | DGAT1 | |
| SCHEMBL15216278 | 0.76 | — | — | |
| SCHEMBL16807263 | 0.76 | DGAT1 (0.39) | DGAT1 | |
| SCHEMBL5613325 | 0.76 | — | — | |
| SCHEMBL12690945 | 0.76 | DGAT1 (0.39) | DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7671135-B2 | Polar monomer-olefin copolymer and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-03-02 | — | — | US | disclosed |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-11-22 | — | — | US | disclosed |
| US-20060223944-A1 | Polar monomer-olefin copolymer and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2006-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | CARM1, CPN1, CCNT1 | DGAT1 4163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.